Breaking News Instant updates and real-time market news.

NARI

Inari Medical

$0.00 /

+ (+0.00%)

06:16
05/22/20
05/22
06:16
05/22/20
06:16

Inari Medical 8.203M share IPO priced at $19.00

The deal size was increased to 8.2M shares of common stock from 7.3M shares of common stock and the deal priced above the revised $17.00-$18.00 range. BofA, Morgan Stanley, Canaccord and Wells Fargo acted as joint book running managers for the offering.

  • 22

    May

TODAY'S FREE FLY STORIES

Downgrade
Hurricane Energy downgraded to Speculative Buy from Buy at Canaccord » 05:14
05/26/20
05/26
05:14
05/26/20
05:14
HRCXF

Hurricane Energy

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRCXF Hurricane Energy
$0.00 /

+ (+0.00%)

01/13/20 BMO Capital
Hurricane Energy downgraded to Market Perform from Outperform at BMO Capital
10/10/19 Barclays
Hurricane Energy upgraded to Overweight from Equal Weight at Barclays
Upgrade
Axcelis upgraded to Buy from Neutral at B. Riley FBR » 05:13
05/26/20
05/26
05:13
05/26/20
05:13
ACLS

Axcelis

$25.01 /

+0.09 (+0.36%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

04/02/20 DA Davidson
Axcelis downgraded to Neutral from Buy at DA Davidson
04/02/20 DA Davidson
Axcelis downgraded to Neutral from Buy at DA Davidson
03/19/20 B. Riley FBR
B. Riley FBR downgrades 10 Semiconductor names on escalating risks
03/19/20 B. Riley FBR
Axcelis downgraded to Neutral from Buy at B. Riley FBR
ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

Downgrade
Kone OYJ downgraded to Hold from Buy at Liberum » 05:12
05/26/20
05/26
05:12
05/26/20
05:12
KNYJY

Kone OYJ

$0.00 /

+ (+0.00%)

Liberum analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNYJY Kone OYJ
$0.00 /

+ (+0.00%)

04/27/20 Berenberg
Kone OYJ price target raised to EUR 49 from EUR 45 at Berenberg
04/24/20 UBS
Kone OYJ price target raised to EUR 53 from EUR 50 at UBS
04/23/20 Barclays
Kone OYJ price target raised to EUR 46 from EUR 40 at Barclays
04/23/20 Morgan Stanley
Kone OYJ price target raised to EUR 47 from EUR 43 at Morgan Stanley
Initiation
CIFI Holdings initiated with a Buy at China Renaissance » 05:08
05/26/20
05/26
05:08
05/26/20
05:08
CFFHF

CIFI Holdings

$0.00 /

+ (+0.00%)

China Renaissance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Flex LNG downgraded to Sell from Buy at Danske Bank » 05:07
05/26/20
05/26
05:07
05/26/20
05:07
FLNG

Flex LNG

$4.85 /

-0.12 (-2.41%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLNG Flex LNG
$4.85 /

-0.12 (-2.41%)

FLNG Flex LNG
$4.85 /

-0.12 (-2.41%)

03/09/20 DNB Markets
Flex LNG downgraded to Hold from Buy at DNB Markets
11/21/19 Nordea
Flex LNG downgraded to Hold from Buy at Nordea
Downgrade
Hoegh LNG Partners downgraded to Sell from Buy at Danske Bank » 05:07
05/26/20
05/26
05:07
05/26/20
05:07
HMLP

Hoegh LNG Partners

$10.44 /

-0.15 (-1.42%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

11/22/19 DNB Markets
Hoegh LNG Partners upgraded to Hold from Sell at DNB Markets
10/29/19 Citi
Hoegh LNG Partners downgraded to Sell from Buy at Citi
10/28/19 DNB Markets
Hoegh LNG Partners downgraded to Sell from Hold at DNB Markets
HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

Recommendations
Acceleron shares not pricing in PAH opportunity, says Piper Sandler » 05:05
05/26/20
05/26
05:05
05/26/20
05:05
XLRN

Acceleron

$98.64 /

-0.43 (-0.43%)

While Acceleron Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

05/12/20 SVB Leerink
Acceleron price target raised to $127 from $104 at SVB Leerink
05/08/20 Credit Suisse
Acceleron price target raised to $123 from $99 at Credit Suisse
04/16/20 Citi
Citi opens 'positive 90-day catalyst watch' on Acceleron
04/06/20 Piper Sandler
Acceleron still top pick after Rebloyzl indication approval, says Piper Sandler
XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

Recommendations
Piper Sandler encouraged by remdesivir results published in NEJM » 05:02
05/26/20
05/26
05:02
05/26/20
05:02
GILD

Gilead

$73.31 /

-0.17 (-0.23%)

The full results from the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/21/20 JPMorgan
Gilead Phase 3 ulcerative colitis study 'mixed at best,' says JPMorgan
05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

Recommendations
Halozyme's Enhanze business nearing accelerated growth, says Piper Sandler » 04:57
05/26/20
05/26
04:57
05/26/20
04:57
HALO

Halozyme

$24.60 /

+0.16 (+0.65%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
$24.60 /

+0.16 (+0.65%)

HALO Halozyme
$24.60 /

+0.16 (+0.65%)

05/12/20 JMP Securities
Halozyme price target raised to $34 from $24 at JMP Securities
05/04/20 Cantor Fitzgerald
Halozyme price target raised to $39 from $35 at Cantor Fitzgerald
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
02/05/20
Fly Intel: Top five analyst upgrades
HALO Halozyme
$24.60 /

+0.16 (+0.65%)

HALO Halozyme
$24.60 /

+0.16 (+0.65%)

Conference/Events
Milestone Scientific to hold a webinar » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
MLSS

Milestone Scientific

$1.87 /

+0.1 (+5.65%)

Interim CEO Osser…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLSS Milestone Scientific
$1.87 /

+0.1 (+5.65%)

Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

Biotech Analysts Nadeau,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Alexion participates in a conference call with Credit Suisse » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
ALXN

Alexion

$101.54 /

+0.31 (+0.31%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

05/15/20 H.C. Wainwright
H.C. Wainwright calls Sarepta 'best of breed' after Pfizer DMD data
05/06/20 Piper Sandler
Piper Sandler remains buyer of Alexion despite frustration
05/05/20 Jefferies
Jefferies sees Portola acquisition as neutral for Alexion
05/05/20 Piper Sandler
Alexion's management deserves benefit of the doubt, says Piper Sandler
ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

Pharmaceuticals Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Gilead participates in a conference call with Credit Suisse » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
GILD

Gilead

$73.31 /

-0.17 (-0.23%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/21/20 JPMorgan
Gilead Phase 3 ulcerative colitis study 'mixed at best,' says JPMorgan
05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

General news
Dallas Fed Mfg Survey General Activity Index to be reported at 10:30 » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

May Dallas Fed Mfg Survey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
4-Week Bill Announcement to be released at 11:00  04:55
05/26/20
05/26
04:55
05/26/20
04:55
 
General news
6-Month Bill Auction to be released at 11:30  04:55
05/26/20
05/26
04:55
05/26/20
04:55
 
General news
3-Month Bill Auction to be released at 11:30  04:55
05/26/20
05/26
04:55
05/26/20
04:55
 
Conference/Events
JMP Securities energy analysts to hold an analyst/industry conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

Energy Analysts provide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
New Home Sales to be reported at 10:00 » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

April New Home Sales will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Bicycle Therapeutics management to meet virtually with Piper Sandler » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
BCYC

Bicycle Therapeutics

$14.45 /

-0.3 (-2.03%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCYC Bicycle Therapeutics
$14.45 /

-0.3 (-2.03%)

BCYC Bicycle Therapeutics
$14.45 /

-0.3 (-2.03%)

04/17/20
Fly Intel: Top five analyst initiations
04/17/20 H.C. Wainwright
Bicycle Therapeutics initiated with a Buy at H.C. Wainwright
04/07/20 Piper Sandler
Bicycle Therapeutics' timelines to be impacted by COVID-19, says Piper Sandler
02/25/20 Piper Sandler
Bicycle Therapeutics price target raised to $30 from $20 at Piper Sandler
BCYC Bicycle Therapeutics
$14.45 /

-0.3 (-2.03%)

BCYC Bicycle Therapeutics
$14.45 /

-0.3 (-2.03%)

General news
FHFA House Price Index M/M change to be reported at 09:00 » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

March FHFA House Price…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Evofem to hold a pharmaceutical update conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
EVFM

Evofem

$4.98 /

+0.18 (+3.75%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

EVFM Evofem
$4.98 /

+0.18 (+3.75%)

04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
12/11/19 H.C. Wainwright
Evofem price target raised to $11 from $9 at H.C. Wainwright
10/16/19 Cantor Fitzgerald
Evofem assumed with an Overweight at Cantor Fitzgerald
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

Conference/Events
Microsoft participates in a conference call with Piper Sandler » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
MSFT

Microsoft

$183.58 /

+0.13 (+0.07%)

Conference call with Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

05/18/20 RBC Capital
Microsoft price target raised to $200 from $196 at RBC Capital
05/15/20 Morgan Stanley
Security another large market opportunity for Microsoft, says Morgan Stanley
05/06/20 Craig-Hallum
MicroVision rise driven by Microsoft speculation, says Craig-Hallum
04/30/20 Credit Suisse
Microsoft price target raised to $195 from $190 at Credit Suisse
MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

MSFT Microsoft
$183.58 /

+0.13 (+0.07%)

Conference/Events
EverQuote participates in a conference call with Canaccord Genuity » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
EVER

EverQuote

$49.00 /

-0.24 (-0.49%)

Internet Analyst Graham…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

05/05/20 Needham
EverQuote price target raised to $55 from $45 at Needham
05/05/20 Canaccord
EverQuote price target raised to $50 from $48 at Canaccord
02/27/20 JMP Securities
EverQuote price target raised to $50 from $35 at JMP Securities
02/26/20 BofA
EverQuote downgraded to Neutral from Buy at BofA
EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

EVER EverQuote
$49.00 /

-0.24 (-0.49%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.